Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial

被引：2
|
作者：
Pfeiler, G.
Koenigsberg, R.
Mlineritsch, B.
Stoger, H.
Singer, C. F.
Poestlberger, S.
Steger, G.
Seifert, M.
Dubsky, P. C.
Jakesz, R.
Samonigg, H.
Bjelic-Radisic, V.
Greil, R.
Marth, C.
Fesl, C.
Gnant, M.
机构：
[1] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria
[2] Inst Translat Res Vienna CEADDP, Vienna, Austria
[3] Paracelsus Univ Salzburg, Salzburg, Austria
[4] Med Univ Klin Graz, Graz, Austria
[5] Med Univ Vienna, Gen Hosp, Vienna, Austria
[6] Hosp Sisters Mercy, Linz, Austria
[7] Med Univ Vienna, Vienna, Austria
[8] Med Univ Vienna, Dept Surg, Vienna, Austria
[9] Med Univ, Dept Internal Med, Graz, Austria
[10] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria
[11] Univ Hosp Salzburg, Dept Med 3, Salzburg, Austria
[12] Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria
[13] Austrian Breast & Colorectal Canc Study Grp, Vienna, Austria
[14] Med Univ Vienna, Dept Surg, Ctr Comprehens Canc, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
514
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of body mass index (BMI) on endocrine therapy in premenopausal breast cancer patients: An analysis of the ABCSG-12 trial.
    Pfeiler, G.
    Koenigsberg, R.
    Singer, C. F.
    Seifert, M.
    Dubsky, P. C.
    Samonigg, H.
    Bjelic-Radisic, V.
    Greil, R.
    Marth, C.
    Gnant, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial
    Pfeiler, Georg
    Koenigsberg, Robert
    Fesl, Christian
    Mlineritsch, Brigitte
    Stoeger, Herbert
    Singer, Christian F.
    Poestlberger, Sabine
    Steger, Guenther G.
    Seifert, Michael
    Dubsky, Peter
    Taucher, Susanne
    Samonigg, Hellmut
    Bjelic-Radisic, Vesna
    Greil, Richard
    Marth, Christian
    Gnant, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (19) : 2653 - 2659
  • [3] Impact of body mass index (BMI) on the efficacy of zoledronic acid in premenopausal patients with hormone receptor positive breast cancer: An analysis of the ABCSG-12 trial.
    Pfeiler, Georg
    Konigsberg, Robert
    Fesl, Christian
    Mlineritsch, Brigitte
    Stoger, Herbert
    Singer, Christian F.
    Poestlberger, Sabine
    Steger, Guenther G.
    Seifert, Michael
    Dubsky, Peter Christian
    Jakesz, Raimund
    Samonigg, Hellmut
    Bjelic-Radisic, Vesna
    Greil, Richard
    Marth, Christian
    Gnant, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Impact of Body Mass Index (BMI) on the Efficacy of Endocrine Therapy in Postmenopausal Breast Cancer Patients - An Analysis of the ABCSG 6 and 6a Trial
    Pfeiler, G.
    Stoeger, H.
    Singer, C.
    Seifert, M.
    Jakesz, R.
    Dubsky, P.
    Samonigg, H.
    Greil, R.
    Menzel, C.
    Heck, D.
    Gnant, M.
    CANCER RESEARCH, 2010, 70
  • [5] Follicle stimulating hormone (FSH) as a surrogate parameter for the effectiveness of endocrine therapy with or without zoledronic acid in premenopausal patients with breast cancer: An analysis of the prospective ABCSG-12 trial
    Pfeiler, Georg
    Koenigsberg, Robert
    Filipcic, Lidija
    Greil, Richard
    Stoger, Herbert
    Singer, Christian F.
    Knauer, Michael
    Steger, Guenther G.
    Seifert, Michael
    Dubsky, Peter Christian
    Fitzal, Florian
    Balic, Marija
    Bjelic-Radisic, Vesna
    Mlineritsch, Brigitte
    Marth, Christian
    Gnant, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] ADJUVANT ENDOCRINE THERAPY, ALONE OR IN COMBINATION WITH ZOLEDRONIC ACID (ZOL), IN PREMENOPAUSAL PATIENTS (PTS) WITH ENDOCRINE-RESPONSIVE EARLY BREAST CANCER (EBC): SUBGROUP ANALYSES OF ABCSG-12
    Gnant, M.
    Mlineritsch, B.
    Stoeger, H.
    Luschin-Ebengreuth, G.
    Poestlberger, S.
    Steger, G. G.
    Jakesz, R.
    Singer, C. F.
    Eidtmann, H.
    Greil, R.
    ANNALS OF ONCOLOGY, 2010, 21 : 79 - 79
  • [7] Androgen receptor expression in pre-menopausal early breast cancer patients treated with endocrine therapy within the ABCSG-12 trial - a single center pilot analysis
    Rinnerthaler, Gabriel
    Knopp, Anna M.
    Hauser-Kronberger, Cornelia
    Gampenrieder, Simon P.
    Morro, Patrick
    Mlineritsch, Brigitte
    Fesl, Christian
    Gnant, Michael
    Greil, Richard
    CANCER RESEARCH, 2015, 75
  • [8] 62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer
    Gnant, M.
    Mlineritsch, B.
    Stoeger, H.
    Luschin-Ebengreuth, G.
    Poestlberger, S.
    Steger, G.
    Jakesz, R.
    Singer, C.
    Eidtmann, H.
    Greil, R.
    BONE, 2011, 48 (01) : S17 - S17
  • [9] Impact of a change of body mass index (BMI) on outcome following adjuvant endocrine therapy, chemotherapy, or trastuzumab for breast cancer
    Yerushalmi, R.
    Dong, B.
    Chapman, J. W.
    Goss, P. E.
    Pollak, M. N.
    Burnell, M. J.
    Bramwell, V. H.
    Levine, M. N.
    Pritchard, K. I.
    Whelan, T. J.
    Ingle, J. N.
    Parulekar, W.
    Shepherd, L. E.
    Gelmon, K. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Cost-effectiveness of zoledronic acid plus endocrine therapy in premenopausal women with early stage breast cancer based on results of the ABCSG-12 study.
    Delea, T. E.
    Taneja, C.
    Sofrygin, O.
    Kaura, S.
    Gnant, M.
    CANCER RESEARCH, 2009, 69 (02) : 190S - 191S
12345